These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


94 related items for PubMed ID: 816715

  • 41. Effect of acute damage from acute rejection and ischemia on long-term renal allograft histology.
    Dennis MJ, Beckingham IJ, Blamey RW.
    Transplant Proc; 1993 Apr; 25(2):2101. PubMed ID: 8470284
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Characteristics of cadaveric renal allograft recipients developing chronic rejection.
    Foster MC, Rowe PA, Dennis MJ, Morgan AG, Burden RP, Blamey RW.
    Ann R Coll Surg Engl; 1990 Jan; 72(1):23-6. PubMed ID: 2301899
    [Abstract] [Full Text] [Related]

  • 44. Prediction of acute renal allograft rejection in early post-transplantation period by soluble CD30.
    Dong W, Shunliang Y, Weizhen W, Qinghua W, Zhangxin Z, Jianming T, He W.
    Transpl Immunol; 2006 Jun; 16(1):41-5. PubMed ID: 16701175
    [Abstract] [Full Text] [Related]

  • 45. [Studies of urinary proteins, FDP (fibrinogen degradation products), and NAG (N-acetyl-beta-D-glucosaminidase) in renal transplanted patients].
    Kunikata S, Ikegami M, Imanishi M, Nishioka T, Ishii T, Uemura T, Kanda H, Matsuura T, Akiyama T, Kurita T.
    Hinyokika Kiyo; 1989 Aug; 35(8):1299-304. PubMed ID: 2816597
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. [Diagnostic significance of the demonstration of fibrin and fibrinogen degradation products in the urine].
    Bendel M, Oetliker O, Montandon A, Beck EA.
    Schweiz Med Wochenschr; 1975 Aug 16; 105(33):1040-7. PubMed ID: 1099647
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Vascular endothelial growth factor (VEGF) ligand and receptor induction in rat renal allograft rejection.
    Rintala SE, Savikko J, Rintala JM, von Willebrand E.
    Transplant Proc; 2006 Dec 16; 38(10):3236-8. PubMed ID: 17175233
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Fibrin in renal disease: functional considerations.
    Wardle EN.
    Clin Nephrol; 1974 Dec 16; 2(3):85-92. PubMed ID: 4604477
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. The fate of glomerular mesangial IgA deposition in the donated kidney after allograft transplantation.
    Ji S, Liu M, Chen J, Yin L, Sha G, Chen H, Liu Z, Li L.
    Clin Transplant; 2004 Oct 16; 18(5):536-40. PubMed ID: 15344956
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. The impact of delayed graft function of the kidney on the pancreas allograft in simultaneous kidney-pancreas transplantation.
    Reddy KS, Stratta RJ, Alloway RR, Lo A, Hodge EE, PIVOT Study Group.
    Transplant Proc; 2004 May 16; 36(4):1078-9. PubMed ID: 15194374
    [Abstract] [Full Text] [Related]

  • 57. Spontaneous improvement of renal function following renal allograft rupture associated with acute rejection.
    Chan TM, Kwok TF, Yap FH, Cheng IK.
    Clin Transplant; 1995 Apr 16; 9(2):71-3. PubMed ID: 7599404
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Immunohistochemical study of endothelin-1 (ET-1) in human acute renal allograft rejection.
    Wagrowska-Danilewicz M, Danilewicz M.
    Pol J Pathol; 2003 Apr 16; 54(2):95-100. PubMed ID: 14575417
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.